Evidence map›Paper›PMID 26622734›Full record

ArticleOncology letters2015

Chronic neutrophilic leukemia with overexpression of EVI-1, and concurrent

Otgonbat Altangerel, Shannan Cao, Juanxia Meng, Peng Liu, Gong Haiyan, Yuanfu Xu, Mingfeng Zhao

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. The impact of SETBP1 mutations in neurological diseases and cancer.Genes to cells : devoted to molecular & cellular mechanisms · 2023
    Review
  2. Somatic SETBP1 mutations in myeloid neoplasms.International journal of hematology · 2017
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Otgonbat AltangerelDepartment of Hematology, Tianjin First Central Hospital, First Central Clinical College of Tianjin Medical University, Tianjin 300192, P.R. China ; Department of Internal Medicine, Division of Hematology, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.
Shannan CaoState Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China.
Juanxia MengDepartment of Hematology, Tianjin First Central Hospital, First Central Clinical College of Tianjin Medical University, Tianjin 300192, P.R. China.
Peng LiuState Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China.
Gong HaiyanState Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China.
Yuanfu XuState Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China.
Mingfeng ZhaoDepartment of Hematology, Tianjin First Central Hospital, First Central Clinical College of Tianjin Medical University, Tianjin 300192, P.R. China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNTianjin Medical University · CNTianjin First Center Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic neutrophilic leukemia (CNL) is a rare type of myeloproliferative neoplasm, characterized by sustained neutrophilia, splenomegaly, bone marrow granulocytic hyperplasia (without evidence of dysplasia) and an absence of the Philadelphia chromosome. Thus far, ~150 cases of CNL have been described in the literature; however, none have demonstrated overexpression of the ecotropic viral integration site-1 (EVI-1, also known as

Indexed as

chronic neutrophilic leukemiacolony stimulating factor 3 receptor mutationecotropic viral integration site-1SET binding receptor mutation

Identifiers

PMID26622734
PMCPMC4533714
OpenAlexW2164844317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.